跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRILIPAN-20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
BRILIPAN-20
Approved
STANDARD
BRILIPAN-20
HETERO LABS LIMITED (UNIT V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1bf30e4a2af15e3f
Company
HETERO LABS LIMITED (UNIT V)
Type
Standard
Approval Details
Approval Id
1bf30e4a2af15e3f
Drug Approval Philippines Name
BRILIPAN-20
Product Name
BRILIPAN-20
Registration Number
DRP-6897-01
Brand Name
BRILIPAN-20
Generic Name
PANTOPRAZOLE (AS SODIUM SESQUIHYDRATE)
Dosage Form
ENTERIC-COATED TABLET
Dosage Strength
20 MG
Manufacturer
HETERO LABS LIMITED (UNIT V)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Mega Lifesciences Limited Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
27 July 2022
Expiry Date
05 June 2027
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1bf30e4a2af15e3f
Type
Standard
Back to Philippines FDA Approvals